BPC 157 Rapid Pro 500mcg Pure Prescriptions FDA Issues Flurry of Warning Letters to Companies Making Unapproved Claims about CBD and Delta 8 Products Buchanan Ingersoll & Rooney PC The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides promoted by RFK Jr. Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA considers adding a dozen peptides to its bulk drug compounding list RAPS